Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags Novo Nordisk A/S Europe Markets Breaking News: Markets
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Health care industry Pfizer Inc AstraZeneca PLC
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags LILLY DRN Biotechnology Business
From CNBC.com News
Zepbound copycats remain online despite FDA ban
Tags Health care industry Retail industry Hims & Hers Health Inc
From CNBC.com News
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Tags Social issues Health & Science Science
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Markets Politics Investment strategy
From CNBC.com News
Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
Tags Breaking News: Europe Markets Europe Markets
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Breaking News: Business Business News Novo Nordisk A/S
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Business News Breaking News: Business Pharmaceuticals
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Alphabet Inc Social issues GE HealthCare Technologies Inc
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags US: News LILLY DRN Biotechnology
From CNBC.com News
Cramer's Lightning Round: Sunoco is a buy
Tags Business Anheuser/Busch Inbev SA Stock markets
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Science LILLY DRN Social issues
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags Bosch Ltd LILLY DRN World Economy
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Tags US: News Government and politics Bristol/Myers Squibb Co
From CNBC.com News
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
Tags Novo Nordisk A/S Health care industry Technology
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags Business News Breaking News: Business Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Tags Novo Nordisk A/S Biotech and Pharmaceuticals LILLY DRN
From CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Business Biotechnology Earnings
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags Science LILLY DRN Social issues
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags U/S/ Markets Pfizer Inc Spotify Technology SA
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags Companies Health care industry US: News
From CNBC.com News
World's largest luxury group LVMH posts better than feared full-year sales
Tags Compagnie Financiere Richemont SA Europe Economy Luxury
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags Medicare LILLY DRN Social issues
From CNBC.com News
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
Tags Biotechnology Breaking News: Europe Pharmaceuticals
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Tags Health & Science Social issues Biotech and Pharmaceuticals
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags Breaking News: Davos Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags Illumina Inc Technology Dexcom Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Companies Social issues Teva Pharmaceutical Industries Ltd
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.